David M. Weiner
Overview
David M. Weiner received an average of $1M in total compensation, including $269K in salary, at aTYR PHARMA between 2014 and 2015.
Source: SEC filing on April 12, 2016.
Related executives
We found nine more executives who work or worked at aTYR PHARMA.
Sanjay Shukla
aTYR PHARMA
Chief Executive Officer
Jill Broadfoot
aTYR PHARMA
Chief Financial Officer
Nancy Denyes
aTYR PHARMA
General Counsel
Ashraf Amanullah
aTYR PHARMA
Former Senior Vice President, Biologics, Development and Manufacturing
David King
aTYR PHARMA
Chief Scientific Officer
John Mendlein
aTYR PHARMA
Chief Executive Officer
Sanuj Ravindran
aTYR PHARMA
Former Chief Business Officer
Kelly Blackburn
aTYR PHARMA